title: Soluble ELAM-1 is elevated with the progression of IgA nephropathy but not with that of polycystic kidney disease.
authors.forename: O
authors.initials: O
authors.lastname: Hotta
authors.forename: Y
authors.initials: Y
authors.lastname: Taguma
authors.forename: N
authors.initials: N
authors.lastname: Yusa
authors.forename: H
authors.initials: H
authors.lastname: Kitamura
authors.forename: K
authors.initials: K
authors.lastname: Sudo
authors.forename: I
authors.initials: I
authors.lastname: Horigome
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D019040:E-Selectin / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005922:Glomerulonephritis, IGA / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007690:Polycystic Kidney Diseases / Q000097:blood* / Q000188:drug therapy; D012016:Reference Values; D013256:Steroids / Q000627:therapeutic use
chemical_list: D019040:E-Selectin; D013256:Steroids; D003404:Creatinine